D-0325-2015 Class II Terminated
FDA drug recall D-0325-2015 was initiated by Zydus Pharmaceuticals USA Inc on Dec 23, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. The recall status is terminated (terminated Sep 22, 2017). Affected quantity: 19,536 units.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 31, 2014
- Initiation Date
- Dec 23, 2014
- Termination Date
- Sep 22, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,536 units
Product description
Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05
Reason for recall
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Distribution pattern
Nationwide
Code information
Lot #: MP2625, MP2626, MP2627 Exp 2/16; MP4875, MP4876, MP4877, MP4878 Exp 4/16; MP6482, MP6483, MP6484, MP6493, MP6494 Exp 6/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0325-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026